A PD-1 Checkpoint Inhibitor (Cemiplimab) for High-Risk Localized, Locally Recurrent, or Regionally Advanced Skin Cancer

Name: A PD-1 Checkpoint Inhibitor (Cemiplimab) for High-Risk Localized, Locally Recurrent, or Regionally Advanced Skin Cancer
License: Public Domain

University of Southern California

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

recurrent skin squamous cell carcinoma, resectable skin squamous cell carcinoma, stage i skin cancer, stage ii skin cancer, stage iii skin cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 369844
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.